In addition, the fact that Nrf2 directly or indirectly regulates antioxidant capacity and the HO-1–iron regulatory-related axis [154,155] indicates that NRF2 activators may become a new approach for the treatment of organ damage in COVID-19. Here, HMOX1 is linked to COVID-19.